In addition, the average tumor growth rate in the shRNA-LMO1 group was much slower than in the control group, although the difference in tumor size at each time point did not reach statistical significance, likely attributable to the small sample size (Figure 4C). The gene discussed is LMO1; the disease is neoplasm.